Novo Nordisk's last-minute plea dismissed by Indian court as patent nears expiry
Novo Nordisk lost its bid to halt Dr. Reddy’s semaglutide exports. The Delhi High Court dismissed the appeal, citing the patent's imminent expiry and the lack of "irreparable loss" caused.Novo Nordisk’s...To view the full article, register now.
Already a subscriber? Click here to view full article